ANTX AN2 Therapeutics, Inc.

Fundamentals / CIK 0001880438 / USD

AN2 Therapeutics, Inc. reported $81.95M in total assets and a net loss of $34.84M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ANTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$60.52MFY 2021 Net Income: -$21.54M2021FY 2022 Net Income: -$40.96M2022FY 2023 Net Income: -$64.73M2023FY 2024 Net Income: -$51.32M2024FY 2025 Net Income: -$35.17M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $24.77M $40.49M $54.87M $28.51M $16.16M
Total Operating Expenses $38.11M $56.79M $69.64M $42.26M $21.57M
Operating Income -$38.11M -$56.79M -$69.64M -$42.26M -$21.57M
Interest Income $2.93M $5.47M $4.86M -- --
Income Tax Expense $0 $0 $0 $0 $0
Net Income -$35.17M -$51.32M -$64.73M -$40.96M -$21.54M
Basic EPS -$1.16 -$1.72 -$2.74 -$2.79 -$10.64
Diluted EPS -$1.16 -$1.72 -$2.74 -$2.79 -$10.64
Basic Shares Outstanding 30.2M 29.8M 23.6M 15.3M 2.6M
Diluted Shares Outstanding 30.2M 29.8M 23.6M 15.3M 2.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.72M $6.02M $6.74M $6.88M $7.00M $3.20M $7.69M $5.40M
Total Operating Expenses $8.67M $8.90M $10.55M $9.32M $10.04M $7.22M $11.54M $8.60M
Operating Income -$8.67M -$8.90M -$10.55M -$9.32M -$10.04M -$7.22M -$11.54M -$8.60M
Interest Income $713K $720K $523K $605K $687K $754K $888K $1.08M
Net Income -$7.96M -$8.19M -$10.03M -$8.67M -$9.35M -$6.46M -$10.65M -$7.52M
Basic EPS -$0.17 -$0.18 -$0.29 -- -$0.31 -$0.21 -$0.35 --
Diluted EPS -$0.17 -$0.18 -$0.29 -- -$0.31 -$0.21 -$0.35 --
Basic Shares Outstanding 46.1M 44.8M 34.1M -- 30.3M 30.2M 30.1M --
Diluted Shares Outstanding 46.1M 44.8M 34.1M -- 30.3M 30.2M 30.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $19.94M $21.35M $15.65M $27.22M $12.10M
Short-Term Investments $38.06M $62.27M $91.65M $68.84M $46.46M
Cash & Short-Term Investments $58.00M $83.62M $107.3M $99.30M $58.55M
Total Current Assets $59.94M $86.26M $110.5M $98.62M $60.11M
Long-Term Investments $2.01M $5.02M $27.19M $3.22M $3.49M
Other Non-Current Assets $0 $804K $1.04M $720K --
Total Non-Current Assets $2.01M $5.83M $28.24M $3.94M $5.21M
Total Assets $61.95M $92.09M $138.7M $102.6M $65.32M
Accounts Payable $3.02M $3.32M $2.68M $2.12M $1.06M
Other Current Liabilities $1.23M $791K $666K -- --
Total Current Liabilities $8.72M $10.24M $14.04M $7.19M $3.40M
Other Non-Current Liabilities $170K $0 -- -- --
Total Non-Current Liabilities $170K $0 $0 $2.0K $13K
Total Liabilities $8.89M $10.24M $14.04M $7.19M $3.41M
Total Debt (incl. Leases) -- -- -- $53K --
Retained Earnings -$240.9M -$205.8M -$154.5M -$89.72M -$47.38M
Accumulated Other Comp. Income $57K $31K $275K -$374K -$27K
Total Stockholders' Equity $53.06M $81.85M $124.7M $95.37M -$47.41M
Total Equity $53.06M $81.85M $124.7M $95.37M -$47.41M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $20.21M $44.32M $53.49M $19.94M $18.00M $18.22M $19.98M $21.35M
Short-Term Investments $44.19M $34.07M $31.80M $38.06M $43.92M $44.70M $47.08M $62.27M
Cash & Short-Term Investments $64.40M $78.39M $85.29M $58.00M $61.92M $62.92M $67.06M $83.62M
Total Current Assets $65.76M $79.99M $87.49M $59.94M $64.02M $67.52M $69.56M $86.26M
Long-Term Investments $15.80M $1.47M $0 $2.01M $3.22M $8.30M $11.48M $5.02M
Other Non-Current Assets $387K $216K -- $0 $0 $0 $304K $804K
Total Non-Current Assets $16.19M $1.69M $0 $2.01M $3.22M $8.30M $11.78M $5.83M
Total Assets $81.95M $81.68M $87.49M $61.95M $67.23M $75.83M $81.34M $92.09M
Accounts Payable $1.66M $1.97M $2.62M $3.02M $2.23M $2.11M $3.07M $3.32M
Other Current Liabilities $945K $776K $567K $1.23M $183K $717K $369K $791K
Total Current Liabilities $6.28M $5.58M $5.56M $8.72M -- -- -- $10.24M
Other Non-Current Liabilities $170K $170K $170K $170K -- -- -- $0
Total Non-Current Liabilities $170K $170K $170K $170K -- -- -- $0
Total Liabilities $6.45M $5.75M $5.73M $8.89M $6.86M $6.98M $8.01M $10.24M
Retained Earnings -$267.1M -$259.2M -$251.0M -$240.9M -$232.2M -$222.9M -$216.4M -$205.8M
Accumulated Other Comp. Income -$207K -$23K -$5.0K $57K $64K $25K $48K $31K
Total Stockholders' Equity $75.51M $75.92M $81.76M $53.06M $60.38M $68.84M $73.33M $81.85M
Total Equity $75.51M $75.92M $81.76M $53.06M $60.38M $68.84M $73.33M $81.85M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$35.17M -$51.32M -$64.73M -$40.96M -$21.54M
Stock-Based Compensation $6.25M $8.34M $8.41M $4.39M $974K
Change in Payables -$296K $641K $553K $2.50M $417K
Operating Cash Flow -$29.83M -$49.26M -$53.29M -$33.46M -$20.48M
Purchases of Investments -$46.19M -$46.75M -$132.2M -$93.84M -$77.27M
Sales & Maturities of Investments $74.50M $101.3M $88.90M $72.06M $27.25M
Investing Cash Flow $28.31M $54.59M -$43.28M -$21.77M -$50.02M
Common Stock Issued $86K $147K $366K -- --
Financing Cash Flow $113K $372K $84.99M $70.36M $78.53M
Net Change in Cash -$1.41M $5.70M -$11.57M $15.12M $8.03M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.96M -$8.19M -$10.03M -$8.71M -$9.35M -$6.46M -$10.65M -$7.52M
Stock-Based Compensation $973K $972K $1.46M $1.40M $801K $2.00M $2.05M $1.78M
Change in Payables $45K -$998K -$405K $795K $113K -$960K -$244K $1.61M
Operating Cash Flow -$6.10M -$7.00M -$12.07M -$5.24M -$6.38M -$7.60M -$10.62M -$5.27M
Purchases of Investments -$33.44M -$13.66M -$2.70M -$8.33M -$3.89M -$11.67M -$22.31M --
Sales & Maturities of Investments $9.00M $10.00M $10.99M $15.50M $10.00M $17.50M $31.50M $17.50M
Investing Cash Flow -$24.44M -$3.66M $8.29M $7.17M $6.11M $5.83M $9.19M -$6.88M
Common Stock Issued -- -- -- $0 $48K $0 $38K $0
Financing Cash Flow $6.43M $1.49M $37.33M $0 $48K $0 $65K $0
Net Change in Cash -$24.11M -$9.17M $33.55M $1.94M -$217K -$1.76M -$1.37M -$12.15M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -66.3% -62.7% -51.9% -42.9% --
Return on Assets (ROA) -56.8% -55.7% -46.7% -39.9% -33.0%
Current Ratio 6.87x 8.43x 7.87x 13.72x 17.70x
Quick Ratio 6.65x 8.17x 7.64x 13.82x 17.25x
Debt to Equity -- -- -- 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -46.1% -47.7% -42.2% -66.2% -56.3% -54.3% -61.8% -62.7%
Return on Assets (ROA) -42.5% -44.4% -39.5% -56.7% -50.5% -49.3% -55.8% -55.7%
Current Ratio 10.48x 14.32x 15.73x 6.87x -- -- -- 8.43x
Quick Ratio 10.26x 14.04x 15.33x 6.65x -- -- -- 8.17x
Source: SEC EDGAR CompanyFacts (CIK 0001880438) · from March 31, 2021 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal